New gene switch activates with simple skin patch and could help treat diabetes
ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...
Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)
PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...
Bio-Convert Develops QR-02, a Potential Breakthrough in the Treatment of Oral Leukoplakia
Bio-Convert ApS (“Bio-Convert”), a subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in supporting Nordic and U.S.
Medscape14d
Treatment of Basal Cell Carcinoma Located in the Head and Neck Region With Intralesional Interferon alpha-2a
The other skin changes in the healing sites were slight erythema (1), hyperpigmentation (2) and hypopigmentation (1). The pre- and post-treatment sizes of the lesions and overall clinical ...
Sensus Healthcare (SRTS) Gets a Buy from Lake Street
Sensus Healthcare (SRTS – Research Report) received a Buy rating and a $18.00 price target from Lake Street analyst Ben Haynor today. The ...
Healio15d
Image-guided superficial radiation therapy mends skin cancer disparities in rural areas
Offering image-guided superficial radiation therapy to rural populations could mend health disparities in nonmelanoma skin cancer treatment, according to a study published in Cancers. Historically ...
Medscape16d
Treatment of Basal Cell Carcinoma Located in the Head and Neck Region With Intralesional Interferon alpha-2a
Objective: Intralesional injections of interferon have been reported to provide successful results in the treatment of basal cell carcinoma. However, there are only a few reports describing the ...
healthday16d
Superficial Curettage May Not Be Noninferior to Excision for Nodular BCC
WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- For patients with nodular basal cell carcinoma (nBCC), it cannot be concluded that superficial curettage (SC) plus imiquimod cream, 5 percent, is ...
AOL18d
Gentle Cure and Medicare: Is it Covered?
Gentle Cure is the brand name for an image-guided superficial ionizing radiation therapy (IG-SRT). It’s a nonsurgical treatment option for basal and squamous cell skin cancers. Gentle Cure uses ...
AOL18d
Medicare and GentleCure: Is it covered?
GentleCure is a brand name of an image-guided superficial ionizing radiation therapy (IG-SRT). This is a nonsurgical treatment option for basal and squamous cell skin cancers. It uses ultrasound ...
Genetically modified virus therapy reduces tumor size and enhances surgical success in skin cancer study
Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to treat surgically. A ...